What is Atomo Diagnostics?
Atomo Diagnostics is headquartered in Australia and specializes in the development and supply of unique, integrated rapid diagnostic test devices for the worldwide diagnostic market. The company's innovative approach aims to simplify testing procedures and improve accessibility to diagnostics globally. Its product portfolio is designed to meet the evolving needs of healthcare providers and patients, offering efficient and reliable diagnostic solutions.
How much funding has Atomo Diagnostics raised?
Atomo Diagnostics has raised a total of $11.8M across 4 funding rounds:
Multiple Rounds
$10.8M
Debt
$1M
Debt (2016): $6M with participation from The Global Health Investment Fund
Grant (2016): $1.4M, investors not publicly disclosed
Private Equity (2016): $3.5M supported by Global Health Investment Fund
Debt (2017): $1M featuring Grand Challenges Canada
Key Investors in Atomo Diagnostics
The Global Health Investment Fund
The Global Health Investment Fund is an impact-focused investment firm that managed the Global Health Investment Fund (GHIF). They specialize in healthcare sector investments, aiming to deliver both financial returns and significant global health improvements through innovative products and services.
Grand Challenges Canada
Grand Challenges Canada is a prominent organization that funds and supports high-impact innovations aimed at saving and improving lives worldwide, with a particular focus on global health challenges and equitable access to healthcare solutions.
Global Health Investment Fund
The Global Health Investment Fund, operating under Global Health Investment Advisors, is dedicated to impact investing within the healthcare sector. They have a history of supporting innovative health products and aim to improve global health outcomes through strategic capital allocation.
What's next for Atomo Diagnostics?
The recent major strategic investment in Atomo Diagnostics signals a pivotal growth phase for the company. This capital infusion is expected to accelerate product development, expand market reach, and enhance manufacturing capabilities. As Atomo Diagnostics continues to scale its operations, it is strategically positioned to capitalize on the growing demand for advanced diagnostic technologies. The company's focus on innovation and its established track record suggest a trajectory towards becoming a key player in the global medical device sector, potentially leading to further strategic partnerships or market expansions.
See full Atomo Diagnostics company page
